Viking Therapeutics Inc (VKTX) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Signals for this name

Every Closelook reading that exists for VKTX, from the same nightly bakes the boards use. Research diary readings, not advice.

GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.

Compared against VKTX on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Versus its index

The name against its Closelook index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-16

DayWeekMonth3 months
VKTX−1.4%−9.7%−12.2%−0.4%
Longevity & Healthspan−0.3%−1.8%−2.6%
HALO Growth 100−0.3%−2.6%−7.2%

Against the index: 7.1 pts behind on the week, 5.0 pts behind on the month; against its Longevity & Healthspan sleeve 9.6 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

About Viking Therapeutics Inc

Viking Therapeutics Inc (VKTX) trades on US exchanges, classified under Healthcare. It is a constituent of HALO Growth 100.

The Closelook company score reads 27/100 composite (momentum 36, quality 1, valuation —) across 6 modules — the full three-layer breakdown, chart structure and analog history load live above.

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-17

Quick answers

What is Viking Therapeutics Inc (VKTX)?

Viking Therapeutics Inc trades as VKTX on the US exchange (US) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-17.

Is VKTX in a Closelook index?

Yes — Viking Therapeutics Inc is a constituent of HALO Growth 100, as of 2026-09-17.

What is Viking Therapeutics Inc's Closelook composite score?

27 out of 100, with momentum 36, quality 1 and valuation n/a sub-scores, as of 2026-09-17. Scores are Closelook's own research readings, not ratings or investment advice.

Where does VKTX trade against its moving averages?

Down 5% at the close: Already below its 50-day; one of the day's sharpest drops. As of 2026-09-15 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

How is VKTX doing against its Closelook index?

Over the past month Viking Therapeutics Inc is −12.2% against −7.2% for the HALO Growth 100 — 5.0 points behind its index, as of 2026-09-16. Its Longevity & Healthspan sleeve is −2.6% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does this page show?

A live price chart with SMA overlays and drawing tools for VKTX, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe